SBC Medical Group (NASDAQ:SBC) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

SBC Medical Group (NASDAQ:SBC) released its quarterly earnings results on Friday. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.03, FiscalAI reports. The firm had revenue of $58.58 million during the quarter, compared to the consensus estimate of $48.90 million. SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%.

Here are the key takeaways from SBC Medical Group’s conference call:

• Q3 growth and margins accelerated: Revenue rose 35% year over year to $59 million, while operating income and Adjusted EBITDA each increased 66%; Adjusted EBITDA margin expanded 9 percentage points to 47%. Management attributed growth partly to revised service fees, equipment-related rental revenue, and the newly consolidated Waqoo segment.
• Existing clinics and the network both grew: Nine-month same-clinic revenue increased 7%, with visits up 9% and average spend per visit up 4%; the network reached 293 locations. Management expects clinic expansion to continue and cited plans to grow general-medicine services and pursue acquisitions.
• AI and longevity are longer-term growth opportunities: SBC is developing diagnostic tests and AI tools for clinic operations and personalized care, with longevity services targeted to contribute meaningfully from around 2028. Management expects AI and network scale to support further margin improvement, but did not quantify the impact or timing.
• No additional share buybacks are planned for now: Despite cash exceeding $200 million, management said it will prioritize acquisitions and new clinic openings, while continuing to focus on improving liquidity.
• Liquidity has improved, while governance changes remain in progress: October average daily trading value was about $1 million, 4.1 times July’s level, and the shareholder base grew 1.6 times. Management said it is advancing the selection of independent directors, but gave no appointment date.

SBC Medical Group Trading Up 36.5%

Shares of SBC stock traded up $1.95 during trading on Friday, hitting $7.29. 1,483,006 shares of the stock traded hands, compared to its average volume of 128,669. The firm has a market capitalization of $749.78 million, a P/E ratio of 15.51, a price-to-earnings-growth ratio of 2.36 and a beta of 0.52. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27. The firm’s fifty day moving average price is $5.07 and its 200-day moving average price is $3.96. SBC Medical Group has a 52-week low of $2.78 and a 52-week high of $7.35.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Wall Street Zen upgraded SBC Medical Group from a “buy” rating to a “strong-buy” rating in a report on Monday, October 5th. Weiss Ratings raised SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Finally, BTIG Research restated a “buy” rating and set a $8.00 price target on shares of SBC Medical Group in a research report on Thursday, August 13th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $8.00.

Recent SBC Medical Group Headlines

Here are a few of the latest headlines about SBC:

• Positive Sentiment: Q3 revenue rose 35% year over year to $58.6 million, beating analyst expectations of $48.9 million. EPS of $0.15 also topped the $0.12 consensus estimate. Net income attributable to SBC increased 22% to $15.7 million, while operating income climbed to $26.4 million from $15.9 million. SBC Medical Q3 financial results
• Positive Sentiment: The company entered a capital and business alliance with NeuroBrain Dynamics, making a minority investment in the AI solutions provider. The partnership plans to apply medical AI to improve clinic profitability, potentially creating operational efficiencies as SBC expands. AI alliance announcement
• Neutral Sentiment: For the first nine months of 2026, revenue increased 13% year over year to $150.8 million. SBC reported $198.4 million in cash and cash equivalents at September 30. Third-quarter and nine-month results

About SBC Medical Group

SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care. The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.